Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 134

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 134
---
 representations and warranties of Kaken will survive the completion of 
 the Divestiture until 12 months following the completion of the Divestiture; and                               |

- 89 -

| • |     | all covenants and other agreements of Aadi, Aadi Sub, Kaken Parent and Kaken contained in the Divestiture 
 Agreement will survive for the period of the applicable statute of limitations with respect thereto.      |

Subject to the terms and conditions of the Divestiture Agreement, Aadi has agreed to indemnify Kaken and its subsidiaries (including Aadi Sub following the closing) and their respective related persons, employees, agents, representatives, successors and assigns for, from and against any and all losses directly or indirectly resulting from, arising out of, suffered, or incurred by Kaken relating to:

| • |     | the failure of certain representations by Aadi, or any representation in any certificate delivered by Aadi                                                                                                                                              
 pursuant to the Divestiture Agreement, to be true and correct in all respects, whether as of the date of the Divestiture Agreement or as of the date of completion of the Divestiture (as if made as of the date of the completion of the Divestiture); |

| • |     | Aadi’s breach of or failure to comply with any covenant or other agreement by Aadi contained in the 
 Divestiture Agreement;                                                                              |

| • |     | Aadi Sub’s breach of or failure to comply with any covenant or other agreement by Aadi Sub contained in the                                    
 Divestiture Agreement, to the extent such covenant or agreement was required to be performed prior to or at the completion of the Divestiture; |

| • |     | all amounts that should have been but were not included in Aadi Sub’s transaction expenses and should as a                             
 result be excluded from the aggregate amount of all cash and cash equivalents held by Aadi Sub upon the completion of the Divestiture; |

| • |     | all fees, costs, expenses and other amounts incurred or otherwise borne by Aadi Sub directly or indirectly to 
 consummate the Pre-Closing Restructuring;                                                                     |

| • |     | certain litigation-related costs; |

| • |     | certain policy exclusions under the RWI Policy; and |

| • |     | certain pre-closing tax matters. |

Limitations on Liability Subject to certain exclusions in the case of claims of fraud against Aadi, the exclusive remedies of Kaken and the other indemnified parties under the